Journal
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
Volume 21, Issue 2, Pages 104-109Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCO.0000000000000441
Keywords
frailty; omega-3 fatty acids; sarcopenia; weakness
Categories
Funding
- NIH [DK 94483, DK 56341, UL1 TR000448]
- Atkins Foundation
- Pershing Square Foundation
Ask authors/readers for more resources
Purpose of review Muscle mass and function decline progressively starting in middle age, which can result in sarcopenia and affect people's mobility and independence later in life. Exercise training and increased protein intake are typically recommended to counteract the age-associated decline in muscle mass and function. However, few people comply with exercise recommendations and the effectiveness of high-protein intake to halt the decline in muscle mass and function has not been proven. This review aims to explore recent developments in the potential for fish-oil derived n-3 polyunsaturated fatty acids (n-3 PUFA) to improve muscle mass and function in older people. Recent findings The results from several recent studies demonstrate that dietary supplementation with fish oil-derived n-3 PUFA stimulates muscle protein synthesis and improves muscle mass and function in sedentary older adults and augments the resistance exercise training-induced increase in muscle strength in older adults. The exact mechanisms by which fish oil-derived n-3 PUFAs exert their beneficial effects on muscle mass and function remain to be elucidated. Summary Fish-oil supplementation has antisarcopenic effects and should be considered in the clinical care of older adults.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available